ClinicalTrials.gg
RecruitingNCT07328685Updated Oct 27, 2026

Basic Body Awareness Therapy in Individuals With Migraine

An interventional study of Exercise and Standart therapy in Migraine, sponsored by Mustafa Kemal University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Mustafa Kemal University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.
Updated Oct 27, 2026Study completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 92 studies in Migraine Disorders with a site in Turkey — 20 open to participants now, 25 under way, 3 of them phase 3. Migraine Disorders · Turkey.

Planned enrollment
54th of 69
40 · median 73
Started
2026
with 8 others
No phase
56 of 92
13 open now
Primary completion
2026-03
later than 13 of 24 live
Registered
80th of 92
by date

Among the 92 studies in Migraine Disorders with a site in Turkey, this one is the 54th largest by planned enrollment of the 69 interventional ones that give a count, is one of 9 that started in 2026, is one of 56 with no phase, reaches primary completion later than 13 of the 24 other live ones, and was the 80th registered.

Migraine Disorders

1,660 studies on the registry are indexed under Migraine Disorders; 340 are open to participants now.

Browse Migraine Disorders studies →

Open to participants now

20 of the 92 studies in Migraine Disorders with a site in Turkey are open now. Recruiting first, the newest first:

14 more — sign in →

All 20 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 217 Migraine Disorders studies recruiting now, 66 (30%) set no upper age limit and 136 (63%) stop at 75 or younger; 44 take children under 18; 37 take healthy volunteers.

This study: 18 Years to 55 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 92 studies in Migraine Disorders with a site in Turkey, or all of them as a file.
02

Study summary

One biopsychosocial approach proven effective in headache treatment is basic body awareness therapy. This study was planned to evaluate the effectiveness of basic body awareness training and lifestyle recommendations in individuals diagnosed with migraine. Functional status will be assessed using the Migraine-Related Disability Assessment Scale (MIDAS), sleep quality using the Jenkins Sleep Scale (JUS), and quality of life using the Headache Impact Test. Assessment of functional status, sleep quality, and quality of life will be performed before treatment and after treatment (at the end of week 8).

03

Conditions studied

  • Migraine

Browse trials for

Keywords

  • migraine
  • functional status
  • sleep
  • quality of life
04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with migraine,
  • Experiencing at least 3 migraine attacks per month,
  • Between the ages of 18 and 55 and who volunteer to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • History of secondary headaches,
  • Being pregnant,
  • Having any other neurological disease besides migraine,
  • Having other secondary headaches in addition to migraine,
  • History of ,
  • Regularly practicing meditation, yoga, or mindfulness-based practices.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Body Awareness Therapy Plus Standard Treatment

    Participants in this group will receive body awareness therapy in addition to standard treatment. The exercise program will be implemented twice over an eight-week period.

    Behavioral: Exercise · Behavioral: Standart therapy

  • Active comparator
    Standart Treatment

    Participants in this group will receive standard treatment without the additional body awareness therapy.

    Behavioral: Standart therapy

Interventions

  • BehavioralExercise

    Participants will receive body awareness therapy. The program will be administered over an eight-week period and will include exercises appropriate for the study population.

  • BehavioralStandart therapy

    Standard treatment will be in the form of individual information sessions lasting approximately 30 minutes for both groups. Brochures will be created for distribution to individuals.

06

What researchers measure

Primary outcomes

  1. Pain Diary

    The severity, duration, and frequency of headaches during attacks will be recorded daily by the participants.

    Time frame: Individuals will be asked to regularly complete a pain diary during the 4-week period before the program, during the program, and during the 4-week follow-up period after the training is completed.

Secondary outcomes

  1. Functional status

    The Migraine Disability Assessment Scale will be used to determine the functional status associated with migraine.

    Time frame: Baseline and at the end of the 8-week intervention

  2. Sleep quality

    Individuals' sleep quality will be assessed using the Jenkins Sleep Scale.

    Time frame: Baseline and at the end of the 8-week intervention

  3. Quality of life related to headaches.

    The Headache Impact Test will be used to assess the impact of headache on quality of life.

    Time frame: Baseline and at the end of the 8-week intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2026 to primary completion in Mar 2026, 2 months.

Of 310 non-industry interventional studies with no phase under Migraine Disorders, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's 2 months is below that.

Counting every sponsor, half of 360 studies reached it within 15 months; a quarter within 7 and three quarters within 33.

Completion moved once since we started tracking on Sep 25, 2026: Aug 2026 → Nov 2026, on Oct 27, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 27, 2025
First posted
Jan 9, 2026
StartActual
Jan 2, 2026
Primary completionActual
Mar 20, 2026
CompletionEst.
Nov 1, 2026was Aug 2026
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Study completion
Aug 1, 2026→Nov 1, 2026
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    Study completion Aug 1, 2026→Nov 1, 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07328685
Lead sponsor
Mustafa Kemal University
Responsible party
Yasemin KARAASLAN (Principal Investigator, Mustafa Kemal University) — Principal investigator
First posted
Jan 9, 2026
Start date
Jan 2, 2026
Primary completion
Mar 20, 2026
Completion
Nov 1, 2026 (estimated)
Last update
Oct 27, 2026

Study contacts

Yasemin Karaaslan, PhD
Contact
ptyasemindeveci@gmail.com
0535 845 96 25

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion